IMCD Valuation Multiples

Discover IMCD's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Luberef, Fertiglobe, ICL Group, SOL and more.

IMCD Overview

About IMCD

IMCD NV manufactures and sells a variety of chemicals and food ingredients. The firm's product portfolio consists of two categories: Life Science consists of the following lines of business: Pharmaceuticals, Beauty & Personal Care, Food & Nutrition, and Home Care and I&I, and The Industrial segment contains the lines of business of Coatings & Construction, Lubricants & Energy, Industrial Solutions and Advanced Materials. The company has four operating segments: EMEA, Americas, Asia-Pacific, and Holding companies. It derives a majority of its revenue from the EMEA segment.


Founded

1995

HQ

Netherlands

Employees

5.1K

Sectors

Financials (LTM)

Revenue: $5.8B
EBITDA: $646M

EV

$7.9B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

IMCD Financials

IMCD reported last 12-month revenue of $5.8B and EBITDA of $646M.

In the same LTM period, IMCD generated $1.4B in gross profit, $646M in EBITDA, and $312M in net income.

Revenue (LTM)


IMCD P&L

In the most recent fiscal year, IMCD reported revenue of $5.6B and EBITDA of $633M.

IMCD is profitable as of last fiscal year, with gross margin of 24%, EBITDA margin of 11%, and net margin of 5%.

See analyst estimates for IMCD
LTMLast FY202320242025202620272028
Revenue$5.8B$5.6B$5.1B$5.4B$5.5B
Gross Profit$1.4B$1.4B$1.3B$1.4B$1.4B
Gross Margin25%24%25%25%25%
EBITDA$646M$633M$651M$676M$578M
EBITDA Margin11%11%13%12%11%
EBIT Margin8%8%10%9%8%
Net Profit$312M$257M$335M$319M$250M
Net Margin5%5%7%6%5%
Net Debt-$1.6B---

Financial data powered by Morningstar, Inc.

IMCD Stock Performance

IMCD has current market cap of $6.2B, and enterprise value of $7.9B.

Market Cap Evolution


IMCD's stock price is $105.57.

IMCD share price increased by 17.0% in the last 30 days, and decreased by 5.0% in the last year.

IMCD has an EPS (earnings per share) of $4.36.

See more trading valuation data for IMCD
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$7.9B$6.2B0.4%17.0%-9.8%-5.0%$4.36

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

IMCD Valuation Multiples

IMCD trades at 1.4x EV/Revenue multiple, and 12.3x EV/EBITDA.

See NTM and 2027E valuation multiples for IMCD

EV / Revenue (LTM)


IMCD Financial Valuation Multiples

As of July 18, 2026, IMCD has market cap of $6.2B and EV of $7.9B.

IMCD has a P/E ratio of 19.9x.

LTMLast FY202320242025202620272028
EV/Revenue1.4x1.4x1.6x1.5x1.4x
EV/EBITDA12.3x12.5x12.2x11.7x13.7x
EV/EBIT17.2x17.8x16.1x16.3x18.6x
EV/Gross Profit5.5x5.8x6.2x5.7x5.8x
P/E19.9x24.2x18.6x19.5x25.0x
EV/FCF21.5x22.4x18.1x27.4x22.9x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified IMCD Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

IMCD Margins & Growth Rates

IMCD grew revenue by 4% and EBITDA by 4% in the last fiscal year.

In the most recent fiscal year, IMCD reported gross margin of 24%, EBITDA margin of 11%, and net margin of 5%.

See estimated margins and future growth rates for IMCD

IMCD Margins

Last FY202420252026202720282029
Gross Margin24%25%25%25%
EBITDA Margin11%12%11%11%
EBIT Margin8%9%8%8%
Net Margin5%6%5%6%
FCF Margin6%5%6%7%

IMCD Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth4%6%1%7%
Gross Profit Growth6%7%(1%)6%
EBITDA Growth4%4%(14%)14%
EBIT Growth7%(1%)(13%)11%
Net Profit Growth40%(5%)(22%)44%
FCF Growth8%(34%)19%10%

Data powered by FactSet, Inc. and Morningstar, Inc.

IMCD Operational KPIs

IMCD's revenue per employee in the last FY averaged $1.1M, while opex per employee averaged $0.2M for the same period.

IMCD's Rule of 40 is 18% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

IMCD's Rule of X is 28% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for IMCD
LTMLast FY202320242025202620272028
Rule of 4015%18%---
Bessemer Rule of X21%28%---
Revenue per Employee-$1.1M---
Opex per Employee-$0.2M---
S&M Expenses to Revenue-3%3%3%3%
G&A Expenses to Revenue-1%1%1%1%
Opex to Revenue-17%16%16%17%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

IMCD Competitors

IMCD competitors include Luberef, Fertiglobe, ICL Group, SOL, Bachem, Perimeter Solutions, Fuchs, Axalta Coating Systems, Croda International and UPL.

Most IMCD public comparables operate across Chemicals.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Luberef2.7x2.4x18.6x11.7x
Fertiglobe2.4x2.2x6.7x5.8x
ICL Group1.3x1.2x6.1x5.8x
SOL3.4x3.3x13.4x12.8x
Bachem7.3x6.2x23.7x20.3x
Perimeter Solutions10.4x8.7x20.4x17.8x
Fuchs1.4x1.3x9.1x9.0x
Axalta Coating Systems1.8x1.8x8.4x8.3x

This data is available for Pro users. Sign up to see all IMCD competitors and their valuation data.

Start Free Trial

Acquisitions by IMCD

IMCD has acquired 36 companies to date.

Last acquisition by IMCD was on June 28th 2026. IMCD acquired Merit Solution for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by IMCD

Merit Solution
Dong Yang FT
Tillmanns
Apus Química
Description
Merit Solution is a chemical wholesaler that procures materials from major international producers for industrial customers.
Dong Yang FT is a South Korean provider of cosmetic raw materials and ingredients. Osan-based, it supplies functional actives, emulsifiers, and preservatives to manufacturers in Asia. The company collaborates on custom formulations for skincare and makeup products meeting global regulatory standards.
Tillmanns is a Milan-based distributor of specialty chemicals and raw materials serving food processing, water treatment, and coatings industries in Italy. Founded in 1924, it supplies enzymes, antimicrobials, and polymers from BASF and Dow to 1,000 manufacturers. Tillmanns operates warehouses in Lombardy stocking 5,000 SKUs with just-in-time delivery across southern Europe.
Apus Química is a Santiago-based manufacturer of performance chemicals tailored for rubber, plastics, and chemical industries in Chile, providing specialized additives and compounds to optimize processing and end-product durability.
HQ CountryThailandSouth KoreaItalyChile
HQ City
Bangkok
Seoul
Milan
Santiago
Deal Date28 Jun 202616 Oct 202527 Aug 202530 Jun 2025
Valuationundisclosedundisclosed$154Mundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all IMCD acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About IMCD

When was IMCD founded?IMCD was founded in 1995.
Where is IMCD headquartered?IMCD is headquartered in Netherlands.
How many employees does IMCD have?As of today, IMCD has over 5K employees.
Is IMCD publicly listed?Yes, IMCD is a public company listed on Euronext Amsterdam.
What is the stock symbol of IMCD?IMCD trades under IMCD ticker.
When did IMCD go public?IMCD went public in 2014.
Who are competitors of IMCD?IMCD main competitors include Luberef, Fertiglobe, ICL Group, SOL, Bachem, Perimeter Solutions, Fuchs, Axalta Coating Systems, Croda International, UPL.
What is the current market cap of IMCD?IMCD's current market cap is $6.2B.
What is the current revenue of IMCD?IMCD's last 12 months revenue is $5.8B.
What is the current revenue growth of IMCD?IMCD revenue growth (NTM/LTM) is 4%.
What is the current EV/Revenue multiple of IMCD?Current revenue multiple of IMCD is 1.4x.
What is the current EBITDA of IMCD?IMCD's last 12 months EBITDA is $646M.
What is IMCD's EBITDA margin?IMCD's last 12 months EBITDA margin is 11%.
What is the current EV/EBITDA multiple of IMCD?Current EBITDA multiple of IMCD is 12.3x.
What is the current FCF of IMCD?IMCD's last 12 months FCF is $369M.
What is IMCD's FCF margin?IMCD's last 12 months FCF margin is 6%.
What is the current EV/FCF multiple of IMCD?Current FCF multiple of IMCD is 21.5x.
How many companies IMCD has acquired to date?As of July 2026, IMCD has acquired 36 companies.
What was the largest acquisition by IMCD?$154M acquisition of Tillmanns on 27th August 2025 was the largest M&A IMCD has done to date.
What companies IMCD acquired?IMCD acquired Tillmanns, Sachs Chemical, KOI Products Solutions & Engineering, Mutchler, VELOX, Zifroni Chemical Suppliers, Feza Kimya Ic Ve Dis Ticaret Anonim Sirketi, Banner Química, TECOM INGREDIENTS, Sanrise, and 26 other companies.
In how many companies IMCD has invested to date?IMCD hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to IMCD

Lists including IMCD

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial